Hill-Rom Holdings Inc. (HRC) Lowered to “Hold” at Zacks Investment Research
According to Zacks, “Post a promising third quarter by Hill-Rom, we are upbeat about the company to remain on a solid growth trajectory over the near term. The company’s year-over-year outcome was impressive along with record level of gross margin. Based on several positive catalysts, we expect the company to expand geographically in the coming quarters. Notably, in the last reported quarter, Hill-Rom posted strong growth in both Asia-Pacific and the U.S. While we remain impressed with the company’s increased bottom-line guidance for fiscal 2016, the revenue guidance was quite discouraging. Moreover, Hill-Rom’s persistent poor performance in the International front, especially in the Middle East and Latin America keeps us concerned. Unfortunately no near term improvement can be expected in the existing capital crunch condition that eventually led to economic and political downturns in these economies.”
HRC has been the topic of several other research reports. Morgan Stanley raised Hill-Rom Holdings from an equal weight rating to an overweight rating and boosted their price target for the stock from $54.00 to $62.00 in a research note on Thursday, June 16th. KeyCorp reissued a buy rating and set a $59.00 price target on shares of Hill-Rom Holdings in a research note on Thursday, June 23rd. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The company has a consensus rating of Buy and a consensus price target of $62.20.
Shares of Hill-Rom Holdings (NYSE:HRC) traded up 0.06% on Wednesday, reaching $61.90. The company had a trading volume of 190,998 shares. The firm has a 50-day moving average price of $59.62 and a 200 day moving average price of $53.30. The firm has a market capitalization of $4.05 billion, a price-to-earnings ratio of 63.75 and a beta of 1.14. Hill-Rom Holdings has a 1-year low of $42.99 and a 1-year high of $62.43.
Hill-Rom Holdings (NYSE:HRC) last announced its quarterly earnings results on Thursday, August 4th. The medical technology company reported $0.81 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.76 by $0.05. The business had revenue of $655.40 million for the quarter, compared to analyst estimates of $647.75 million. Hill-Rom Holdings had a return on equity of 16.62% and a net margin of 2.47%. The company’s quarterly revenue was up 38.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.62 EPS. Equities research analysts predict that Hill-Rom Holdings will post $3.33 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, September 30th. Investors of record on Friday, September 16th were given a dividend of $0.17 per share. The ex-dividend date of this dividend was Wednesday, September 14th. This represents a $0.68 annualized dividend and a dividend yield of 1.10%. Hill-Rom Holdings’s dividend payout ratio is currently 73.91%.
Several hedge funds and other institutional investors have recently modified their holdings of HRC. Globeflex Capital L P increased its position in shares of Hill-Rom Holdings by 0.3% in the second quarter. Globeflex Capital L P now owns 44,493 shares of the medical technology company’s stock valued at $2,245,000 after buying an additional 155 shares during the period. State Treasurer State of Michigan increased its position in shares of Hill-Rom Holdings by 0.9% in the second quarter. State Treasurer State of Michigan now owns 22,850 shares of the medical technology company’s stock valued at $1,153,000 after buying an additional 200 shares during the period. Capstone Asset Management Co. increased its position in shares of Hill-Rom Holdings by 4.2% in the second quarter. Capstone Asset Management Co. now owns 7,225 shares of the medical technology company’s stock valued at $365,000 after buying an additional 290 shares during the period. Stifel Financial Corp increased its position in shares of Hill-Rom Holdings by 10.0% in the second quarter. Stifel Financial Corp now owns 4,955 shares of the medical technology company’s stock valued at $250,000 after buying an additional 451 shares during the period. Finally, Oregon Public Employees Retirement Fund increased its position in shares of Hill-Rom Holdings by 2.5% in the second quarter. Oregon Public Employees Retirement Fund now owns 18,921 shares of the medical technology company’s stock valued at $955,000 after buying an additional 461 shares during the period. Hedge funds and other institutional investors own 83.11% of the company’s stock.
Hill-Rom Holdings Company Profile
Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.